The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic

Nektar Therapeutics Stock Soars Amid Intense Takeover Speculation

Bavarian Nordic's Future Intensifies: A Higher Bid Ignites Take-Private Battle

FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review

Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target

HCW Biologics Skyrockets 102% Overnight: What's Fueling the Biotech Boom?

Harbour BioMed Welcomes Dr. Yajie Li as New Chief Medical Officer

Rocket Soars: Why Rocket Pharmaceuticals Stock Just Exploded Over 15%!

CARsgen Therapeutics Unveils Stellar 2025 Interim Achievements: A Deep Dive into Innovation and Growth

Soligenix Soars: Groundbreaking Progress and Robust Financials Propel Q2 2025 Success